ArticleMedComm2026

Hepatic Arterial Infusion Chemotherapy plus either Toripalimab or Sorafenib as First-line Therapy for Locally Advanced Hepatocellular Carcinoma: A Non-comparative, Randomized Phase 2 Trial.

Zhicheng Lai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.